| 1 | Poor long-term outcome in patients with porto-sinusoidal vascular disease (PSVD): fact or disease misclassification? | 2.9 | 3 | Citations (PDF) |
| 2 | Reply to: “A consensus definition for ACLF – The need of the hour?” | 2.9 | 0 | Citations (PDF) |
| 3 | Prognostic Role of Serum Vascular Endothelial Growth Factor and Hepatocyte Growth Factor Post Stereotactic Body Radiation in Advanced Hepatocellular Carcinoma | 1.0 | 0 | Citations (PDF) |
| 4 | Idiopathic Non-Cirrhotic Portal Hypertension and Fibrosis | 0.9 | 0 | Citations (PDF) |
| 5 | Hepatic encephalopathy in non-cirrhotic portal hypertension | 3.0 | 0 | Citations (PDF) |
| 6 | Predictors of Non-response to Atezolizumab Plus Bevacizumab in Patients With Unresectable Hepatocellular Carcinoma: A Multicentre Real World Study (HCC-AB Study) | 1.0 | 0 | Citations (PDF) |
| 7 | A global action agenda for turning the tide on fatty liver disease | 11.6 | 26 | Citations (PDF) |
| 8 | Reply to: “Target mean arterial pressure in critically ill cirrhotic patients with septic shock: More is not always better!” | 2.9 | 0 | Citations (PDF) |
| 9 | Targeted <scp>HBx</scp> gene editing by <scp>CRISPR</scp>/Cas9 system effectively reduces epithelial to mesenchymal transition and <scp>HBV</scp> replication in hepatoma cells | 4.2 | 3 | Citations (PDF) |
| 10 | High prevalence of MAFLD in general population: A large cross‐sectional study calls for concerted public health action | 4.0 | 8 | Citations (PDF) |
| 11 | Liver volumetry in cirrhotic patients with or without hepatocellular carcinoma: Its correlation with Child–Pugh, model for end-stage liver diseases and indocyanine green dye test | 1.5 | 0 | Citations (PDF) |
| 12 | Comparative metabolome analysis reveals higher potential of haemoperfusion adsorption in providing favourable outcome in <scp>ACLF</scp> patients | 4.2 | 3 | Citations (PDF) |
| 13 | Editorial: The tsunami of steatotic liver disease in India, the Asia‐Pacific region and the world—Authors' reply | 4.0 | 0 | Citations (PDF) |
| 14 | Acute-on-chronic liver failure – steps towards harmonization of the definition! | 2.9 | 9 | Citations (PDF) |
| 15 | APASL clinical practice guidelines on the management of acute kidney injury in acute-on-chronic liver failure | 4.5 | 6 | Citations (PDF) |
| 16 | Midodrine plus propranolol versus propranolol alone in preventing first bleed in patients with cirrhosis and severe ascites: a randomized controlled trial | 4.5 | 2 | Citations (PDF) |
| 17 | Noncirrhotic portal hypertension—Historical perspectives bring clarity to the entity and its management | 1.4 | 0 | Citations (PDF) |
| 18 | Effect of midodrine on <scp>HVPG</scp> in advanced chronic liver disease and acute‐on‐chronic liver failure—A pilot study | 4.2 | 2 | Citations (PDF) |
| 19 | Combination of carvedilol with variceal band ligation in prevention of first variceal bleed in Child-Turcotte-Pugh B and C cirrhosis with high-risk oesophageal varices: the ‘CAVARLY TRIAL’ | 14.8 | 6 | Citations (PDF) |
| 20 | Acute-on-chronic liver failure in metabolic dysfunction-associated fatty liver disease patients: a disease multiplier | 4.5 | 0 | Citations (PDF) |
| 21 | Comparative effectiveness of different corticosteroid regimens in severe alcohol-associated hepatitis | 4.9 | 0 | Citations (PDF) |
| 22 | Non-cirrhotic portal fibrosis/idiopathic portal hypertension: APASL recommendations for diagnosis and management | 4.5 | 2 | Citations (PDF) |
| 23 | <scp>APASL‐ACLF</scp> Research Consortium–Artificial Intelligence (<scp>AARC‐AI</scp>) model precisely predicts outcomes in <scp>acute‐on‐chronic</scp> liver failure patients | 4.2 | 8 | Citations (PDF) |
| 24 | Much More Is Needed From Hepatitis B Core-Related Antigen to Predict Risk of Liver Cancer | 0.4 | 1 | Citations (PDF) |
| 25 | Immune predictors of hepatitis B surface antigen seroconversion in patients with hepatitis B reactivation | 4.0 | 8 | Citations (PDF) |
| 26 | Etiologic fractions in patients of hepatocellular carcinoma in India with and without a background of cirrhosis: a multi-centric study | 4.5 | 13 | Citations (PDF) |
| 27 | Management of Gastric and Ectopic Varices | 0.9 | 0 | Citations (PDF) |
| 28 | Combination of GM CSF and carbapenem is superior to carbapenem monotherapy in difficult‐to‐treat spontaneous bacterial peritonitis: A randomized controlled trial | 4.2 | 6 | Citations (PDF) |
| 29 | Emergent rescue transjugular intrahepatic portosystemic shunt within 8 h improves survival in patients with refractory variceal bleed | 4.5 | 4 | Citations (PDF) |
| 30 | Identifying the early predictors of non-response to steroids in patients with flare of autoimmune hepatitis causing acute-on-chronic liver failure | 4.5 | 3 | Citations (PDF) |
| 31 | Acute-on-chronic liver failure: Terminology, mechanisms and management | 8.3 | 23 | Citations (PDF) |
| 32 | Hepatopulmonary syndrome is associated with low sphingosine-1-phosphate levels and can be ameliorated by the functional agonist fingolimod | 2.9 | 6 | Citations (PDF) |
| 33 | A randomised-controlled trial (TARGET-C) of high vs. low target mean arterial pressure in patients with cirrhosis and septic shock | 2.9 | 23 | Citations (PDF) |
| 34 | The bidirectional impacts of alcohol consumption and MAFLD for progressive fatty liver disease | 4.1 | 7 | Citations (PDF) |
| 35 | Immune drivers of HBsAg loss in HBeAg-negative CHB patients after stopping nucleotide analog and administration of Peg-IFN | 4.9 | 5 | Citations (PDF) |
| 36 | Non‐resolution of acute kidney injury in the first week portends the development of chronic kidney disease in critically ill patients with cirrhosis | 4.0 | 7 | Citations (PDF) |
| 37 | Reply to: Correspondence on “Hepatopulmonary syndrome is associated with low sphingosine-1-phosphate levels and can be ameliorated by the functional agonist fingolimod” | 2.9 | 2 | Citations (PDF) |
| 38 | Uniting to defeat steatotic liver disease: A global mission to promote healthy livers and healthy lives | 2.9 | 12 | Citations (PDF) |
| 39 | Metabolic alterations unravel the maternofetal immune responses with disease severity in pregnant women infected with SARS‐CoV‐2 | 3.8 | 0 | Citations (PDF) |
| 40 | Severity of Acute Portal Hypertension Determines the Clinical Outcomes in Severe Alcoholic Hepatitis | 2.2 | 2 | Citations (PDF) |
| 41 | Standard-Volume Plasma Exchange Improves Outcomes in Patients With Acute Liver Failure: A Randomized Controlled Trial | 6.4 | 100 | Citations (PDF) |
| 42 | Early Allograft Dysfunction After Live Donor Liver Transplantation: It's Time to Redefine? | 1.0 | 7 | Citations (PDF) |
| 43 | Clinical Outcomes of Transcatheter Arterial Embolization Using N-butyl-2-cyanoacrylate (NBCA) in Cirrhotic Patients | 1.0 | 4 | Citations (PDF) |
| 44 | Evaluation of the Integrative Weaning Index for Predicting the Outcome of Spontaneous Breathing Trial in Patients with Cirrhosis on Mechanical Ventilation: A Pilot Study 2022, 50, 107-113 | | 1 | Citations (PDF) |
| 45 | G-CSF in acute-on-chronic liver failure – Art of ‘patient selection’ is paramount! | 2.9 | 7 | Citations (PDF) |
| 46 | Response evaluation of locoregional therapies in combined hepatocellular–cholangiocarcinoma and intrahepatic cholangiocarcinoma versus hepatocellular carcinoma: a propensity score matched study | 1.1 | 4 | Citations (PDF) |
| 47 | Protocol for global proteome, virome, and metaproteome profiling of respiratory specimen (VTM) in COVID-19 patient by LC-MS/MS-based analysis | 1.1 | 5 | Citations (PDF) |
| 48 | Feasibility, effectiveness and cost of a decentralized HCV care model among the general population in Delhi, India | 4.2 | 9 | Citations (PDF) |
| 49 | CEACAM-1 Induced CSF3-receptor Downregulation in Bone Marrow Associated With Refractory Neutropenia in Advanced Cirrhosis | 2.2 | 1 | Citations (PDF) |
| 50 | Liver stiffness can predict decompensation and need for beta-blockers in compensated cirrhosis: a step beyond Baveno-VI criteria | 4.5 | 7 | Citations (PDF) |
| 51 | Asian Pacific association for the study of liver (APASL) guidelines: hepatitis B virus in pregnancy | 4.5 | 42 | Citations (PDF) |
| 52 | Clinical Outcomes in Patients with Advanced Chronic Liver Disease and Hepatic Venous Pressure Gradient ≤ 10 mm Hg | 2.2 | 2 | Citations (PDF) |
| 53 | Health and economic burden due to alcohol-associated liver diseases in the Union Territory of Delhi: A Markov probabilistic model approach | 1.5 | 1 | Citations (PDF) |
| 54 | Effect of long-term aggressive nutrition therapy on survival in patients with alcohol-related cirrhosis: A randomized controlled trial | 1.5 | 7 | Citations (PDF) |
| 55 | SARS-CoV-2 Lineage Tracking, and Evolving Trends Seen during Three Consecutive Peaks of Infection in Delhi, India: a Clinico-Genomic Study | 3.6 | 4 | Citations (PDF) |
| 56 | Vaccine Breakthrough Infections by SARS-CoV-2 Variants after ChAdOx1 nCoV-19 Vaccination in Healthcare Workers | 3.1 | 10 | Citations (PDF) |
| 57 | A randomized-controlled trial comparing 20% albumin to plasmalyte in patients with cirrhosis and sepsis-induced hypotension [ALPS trial] | 2.9 | 48 | Citations (PDF) |
| 58 | Hepatic Arterioportal Fistula in Patients with Cirrhosis with Endovascular Management—A Series of 4 Cases with Review of Literature | 0.8 | 2 | Citations (PDF) |
| 59 | Efficacy of convalescent plasma therapy in the patient with COVID-19: a randomised control trial (COPLA-II trial) | 2.0 | 17 | Citations (PDF) |
| 60 | Soluble factors and suppressive monocytes can predict early development of sepsis in acute‐on‐chronic liver failure | 4.9 | 10 | Citations (PDF) |
| 61 | Epidemiology of liver failure in <scp>Asia‐Pacific</scp> region | 4.2 | 17 | Citations (PDF) |
| 62 | ABC: a novel algorithm to stratify decompensation risk in patients with compensated advanced chronic liver disease (CHESS2108): an international, multicenter cohort study | 4.5 | 3 | Citations (PDF) |
| 63 | Bioenergetic Failure Drives Functional Exhaustion of Monocytes in Acute-on-Chronic Liver Failure | 5.0 | 11 | Citations (PDF) |
| 64 | Granulocyte-Macrophage Colony-Stimulating Factor Modulates Myeloid-Derived Suppressor Cells and Treg Activity in Decompensated Cirrhotic Patients With Sepsis | 5.0 | 11 | Citations (PDF) |
| 65 | CYTOMEGALOVIRUS REACTIVATION IN SEROPOSITIVE CRITICALLY ILL PATIENTS WITH LIVER CIRRHOSIS: A HOSPITAL-BASED LONGITUDINAL STUDY | 0.9 | 0 | Citations (PDF) |
| 66 | International multicenter validation of <scp>GES</scp> score for <scp>HCC</scp> risk stratification in chronic hepatitis C patients | 2.1 | 8 | Citations (PDF) |
| 67 | Metabolic (dysfunction)-associated fatty liver disease in individuals of normal weight | 14.7 | 132 | Citations (PDF) |
| 68 | Intragastric Balloon in Obese Compensated Nonalcoholic Steatohepatitis Cirrhosis Patients Is Safe and Achieves Significant Weight Reduction at 6-Months | 2.2 | 6 | Citations (PDF) |
| 69 | Acute variceal bleeding portends poor outcomes in patients with acute-on-chronic liver failure: a propensity score matched study from the APASL ACLF Research Consortium (AARC) | 4.5 | 13 | Citations (PDF) |
| 70 | Natural history, spectrum and outcome of stage 3 <scp>AKI</scp> in patients with acute‐on‐chronic liver failure | 4.2 | 11 | Citations (PDF) |
| 71 | Comparison of safety and efficacy of convalescent plasma with fresh frozen plasma in severe covid-19 patients | 0.8 | 6 | Citations (PDF) |
| 72 | Influence of shunt occlusion on liver volume and functions in hyperammonemic cirrhosis patients having large porto-systemic shunts: a randomized control trial | 4.5 | 12 | Citations (PDF) |
| 73 | Reply to: “Response to: A randomized-controlled trial comparing 20% albumin to plasmalyte in patients with cirrhosis and sepsis-induced hypotension [ALPS trial]” | 2.9 | 0 | Citations (PDF) |
| 74 | PIRO-CIC model can predict mortality and futility of care in critically ill cirrhosis patients in the intensive care unit | 4.5 | 4 | Citations (PDF) |
| 75 | Assessment of the Performance of Non-invasive Criteria for the Evaluation of Clinically Significant Portal Hypertension in Patients with Compensated Advanced Chronic Liver Disease | 2.2 | 4 | Citations (PDF) |
| 76 | Low-dose continuous terlipressin infusion is effective and safer than intravenous bolus injections in reducing portal pressure and control of acute variceal bleeding | 4.5 | 14 | Citations (PDF) |
| 77 | Fecal microbiota transplantation compared with prednisolone in severe alcoholic hepatitis patients: a randomized trial | 4.5 | 43 | Citations (PDF) |
| 78 | AARC score determines outcomes in patients with alcohol-associated hepatitis: a multinational study | 4.5 | 8 | Citations (PDF) |
| 79 | Liver Transplantation Society of India Guidelines for the Management of Acute Liver Injury Secondary to Yellow Phosphorus–Containing Rodenticide Poisoning Using the Modified Delphi Technique of Consensus Development | 1.0 | 14 | Citations (PDF) |
| 80 | Hepatocellular carcinoma: Clinicopathologic associations amidst marked phenotypic heterogeneity | 3.0 | 2 | Citations (PDF) |
| 81 | The Indian Network of Drug-Induced Liver Injury: Etiology, Clinical Features, Outcome and Prognostic Markers in 1288 Patients | 1.0 | 52 | Citations (PDF) |
| 82 | Letter to the Editor: Relevance of Circulating Extracellular Vesicles Carrying Sphingolipid Cargo in Alcoholic Hepatitis: Need for More Validation! | 11.6 | 1 | Citations (PDF) |
| 83 | Degree of Portal and Systemic Hemodynamic Alterations Predict Recurrent AKI and Chronic Kidney Disease in Patients With Cirrhosis | 4.9 | 5 | Citations (PDF) |
| 84 | Management Practices and Predictors of Outcome of Liver Abscess in Adults: A Series of 1630 Patients from a Liver Unit | 1.0 | 23 | Citations (PDF) |
| 85 | Identification of miRNAs associated with dendritic cell dysfunction during acute and chronic hepatitis B virus infection | 3.8 | 10 | Citations (PDF) |
| 86 | Impact of metabolic risk factors on the severity and outcome of patients with alcohol‐associated acute‐on‐chronic liver failure | 4.2 | 18 | Citations (PDF) |
| 87 | Number needed to screen to prevent progression of liver fibrosis to cirrhosis at primary health centers | 1.1 | 1 | Citations (PDF) |
| 88 | Alcohol associated liver cirrhotics have higher mortality after index hospitalization: Long-term data of 5,138 patients | 8.3 | 15 | Citations (PDF) |
| 89 | Omega‐3 fatty acid lipid emulsions are safe and effective in reducing endotoxemia and sepsis in acute‐on‐chronic liver failure: An open‐label randomized controlled trial | 2.8 | 31 | Citations (PDF) |
| 90 | Comparative Analysis of Radiofrequency Ablation and Microwave Ablation for Critically Located Hepatocellular Carcinomas Smaller than 5 cm | 0.4 | 0 | Citations (PDF) |
| 91 | Co‐orchestration of acute kidney injury and non‐kidney organ failures in critically ill patients with cirrhosis | 4.2 | 14 | Citations (PDF) |
| 92 | Drug-induced liver injury: Asia Pacific Association of Study of Liver consensus guidelines | 4.5 | 91 | Citations (PDF) |
| 93 | Survival and Outcome in Patients Receiving Drug-Eluting Beads Transarterial Chemoembolization for Large Hepatocellular Carcinoma (>5 cm) | 1.0 | 8 | Citations (PDF) |
| 94 | Efficacy of combining pentoxiphylline and vitamin E versus vitamin E alone in non-alcoholic steatohepatitis— A randomized pilot study | 1.5 | 11 | Citations (PDF) |
| 95 | Chronic hepatitis B: the demise of the ‘inactive carrier’ phase | 4.5 | 27 | Citations (PDF) |
| 96 | Therapeutic plasma‐exchange improves systemic inflammation and survival in acute‐on‐chronic liver failure: A propensity‐score matched study from AARC | 4.2 | 38 | Citations (PDF) |
| 97 | Pooled nasopharyngeal swab collection in a single vial for the diagnosis of SARS CoV-2 infection: An effective cost saving method | 1.1 | 7 | Citations (PDF) |
| 98 | Retrospective comparative study of efficacy, safety and outcome of percutaneous intervention for Budd-Chiari syndrome patients with bilirubin less than 3 and 3–6 mg/dl | 2.6 | 4 | Citations (PDF) |
| 99 | Circulating extracellular vesicles induce monocyte dysfunction and are associated with sepsis and high mortality in cirrhosis | 4.2 | 5 | Citations (PDF) |
| 100 | The Asian Pacific Association for the Study of the Liver clinical practice guidance: the diagnosis and management of patients with autoimmune hepatitis | 4.5 | 46 | Citations (PDF) |
| 101 | Transarterial Chemoembolization in Unresectable Hepatocellular Carcinoma with Portal Vein Tumor Thrombosis: A Tertiary Care Center Experience | 0.8 | 6 | Citations (PDF) |
| 102 | Second-harmonic generation (SHG) microscopy and hepatic venous pressure gradient-based validation of a novel histological staging system for alcoholic hepatitis | 2.7 | 0 | Citations (PDF) |
| 103 | Comparison of 5% human albumin and normal saline for fluid resuscitation in sepsis induced hypotension among patients with cirrhosis (FRISC study): a randomized controlled trial | 4.5 | 51 | Citations (PDF) |
| 104 | Development of a machine learning model to predict bleed in esophageal varices in compensated advanced chronic liver disease: A proof of concept | 2.8 | 17 | Citations (PDF) |
| 105 | Comparative accuracy of prognostic models for short-term mortality in acute-on-chronic liver failure patients: CAP-ACLF | 4.5 | 19 | Citations (PDF) |
| 106 | Budd-Chiari syndrome: consensus guidance of the Asian Pacific Association for the study of the liver (APASL) | 4.5 | 49 | Citations (PDF) |
| 107 | Differential blood transcriptome modules predict response to corticosteroid therapy in alcoholic hepatitis | 5.5 | 8 | Citations (PDF) |
| 108 | Dynamic assessments of hepatic encephalopathy and ammonia levels predict mortality in acute-on-chronic liver failure | 4.5 | 35 | Citations (PDF) |
| 109 | The search for disease-modifying agents in decompensated cirrhosis: From drug repurposing to drug discovery | 2.9 | 43 | Citations (PDF) |
| 110 | Plasma Exchange in Acute and Acute on Chronic Liver Failure | 3.4 | 25 | Citations (PDF) |
| 111 | APASL clinical practice guideline on hepatitis B reactivation related to the use of immunosuppressive therapy | 4.5 | 87 | Citations (PDF) |
| 112 | Primary prophylaxis of gastric variceal bleeding: the choices need to be tested!! | 4.5 | 6 | Citations (PDF) |
| 113 | Multi-omics analysis of respiratory specimen characterizes baseline molecular determinants associated with SARS-CoV-2 outcome | 3.8 | 27 | Citations (PDF) |
| 114 | Establishment of a murine model of acute-on-chronic liver failure with multi-organ dysfunction | 4.5 | 17 | Citations (PDF) |
| 115 | Elevated plasma ICAM1 levels predict 28-day mortality in cirrhotic patients with COVID-19 or bacterial sepsis | 5.5 | 23 | Citations (PDF) |
| 116 | Reversal of Feed Intolerance by Prokinetics Improves Survival in Critically Ill Cirrhosis Patients | 2.2 | 5 | Citations (PDF) |
| 117 | Albumin in Advanced Liver Diseases: The Good and Bad of a Drug! | 11.6 | 51 | Citations (PDF) |
| 118 | Letter to the Editor | 11.6 | 0 | Citations (PDF) |
| 119 | Integration of public health measures for NAFLD into India's national programme for NCDs | 22.9 | 12 | Citations (PDF) |
| 120 | Higher circulating natural killer cells and lower lactate levels at admission predict spontaneous survival in non-acetaminophen induced acute liver failure | 2.2 | 3 | Citations (PDF) |
| 121 | Insights into the Role of Granulocyte Colony-Stimulating Factor in Severe Alcoholic Hepatitis | 3.4 | 9 | Citations (PDF) |
| 122 | Liver Transplantation Reverses Hepatic Myelopathy in 2 Children With Hepatitis A Infection | 0.9 | 3 | Citations (PDF) |
| 123 | ‘First week’ is the crucial period for deciding living donor liver transplantation in patients with acute-on-chronic liver failure | 4.5 | 19 | Citations (PDF) |
| 124 | Advancing the global public health agenda for NAFLD: a consensus statement | 14.7 | 432 | Citations (PDF) |
| 125 | Metronidazole-related neurotoxicity in a referral hospital | 0.3 | 0 | Citations (PDF) |
| 126 | Impact of compensated cirrhosis on survival in patients with acute-on-chronic liver failure | 4.5 | 8 | Citations (PDF) |
| 127 | The MELD Score Is Superior to the Maddrey Discriminant Function Score to Predict Short-Term Mortality in Alcohol-Associated Hepatitis: A Global Study | 0.4 | 51 | Citations (PDF) |
| 128 | MAFLD considerations as a part of the global hepatitis C elimination effort: an international perspective | 4.0 | 30 | Citations (PDF) |
| 129 | Congenital Extrahepatic Portosystemic Shunts (Abernethy Malformation): An International Observational Study | 11.6 | 116 | Citations (PDF) |
| 130 | Thromboelastography‐Guided Blood Component Use in Patients With Cirrhosis With Nonvariceal Bleeding: A Randomized Controlled Trial | 11.6 | 139 | Citations (PDF) |
| 131 | Terlipressin Is Superior to Noradrenaline in the Management of Acute Kidney Injury in Acute on Chronic Liver Failure | 11.6 | 154 | Citations (PDF) |
| 132 | Incidence, Risk Factors, and Outcomes of Transition of Acute Kidney Injury to Chronic Kidney Disease in Cirrhosis: A Prospective Cohort Study | 11.6 | 59 | Citations (PDF) |
| 133 | Heparin-like Effect Associated With Risk of Bleeding, Sepsis, and Death in Patients With Severe Alcohol-Associated Hepatitis | 6.4 | 17 | Citations (PDF) |
| 134 | Feasibility of 4D CT simulation with synchronized intravenous contrast injection in hepatocellular carcinoma | 1.0 | 6 | Citations (PDF) |
| 135 | Hyperoxidized Albumin Modulates Platelets and Promotes Inflammation Through CD36 Receptor in Severe Alcoholic Hepatitis | 4.9 | 15 | Citations (PDF) |
| 136 | Combined Balloon-, Plug- and Coil-assisted Retrograde Transvenous Obliteration of Multiple Portosystemic Shunts to Treat Recurrent Hepatic Encephalopathy: A Case Report | 1.0 | 0 | Citations (PDF) |
| 137 | Liver diseases in the Asia-Pacific region: a Lancet Gastroenterology & Hepatology Commission | 22.9 | 375 | Citations (PDF) |
| 138 | Paracentesis‐Induced Circulatory Dysfunction With Modest‐Volume Paracentesis Is Partly Ameliorated by Albumin Infusion in Acute‐on‐Chronic Liver Failure | 11.6 | 52 | Citations (PDF) |
| 139 | Carvedilol Combined With Ivabradine Improves Left Ventricular Diastolic Dysfunction, Clinical Progression, and Survival in Cirrhosis | 2.5 | 33 | Citations (PDF) |
| 140 | Natural Killer Cells Contribute to Pathogenesis of Severe Alcoholic Hepatitis by Inducing Lysis of Endothelial Progenitor Cells | 2.7 | 7 | Citations (PDF) |
| 141 | The Asian Pacific Association for the Study of the Liver clinical practice guidelines for the diagnosis and management of metabolic associated fatty liver disease | 4.5 | 522 | Citations (PDF) |
| 142 | Plug-Assisted Retrograde Transvenous Obliteration (PARTO): Anatomical Factors Determining Procedure Outcome | 1.8 | 8 | Citations (PDF) |
| 143 | Role of EEG in Predicting Outcome of Hepatic Encephalopathy Patients | 0.4 | 10 | Citations (PDF) |
| 144 | Pooled RNA sample reverse transcriptase real time PCR assay for SARS CoV-2 infection: A reliable, faster and economical method | 2.5 | 39 | Citations (PDF) |
| 145 | Elevated levels of systemic bacterial vesicles in autoimmune hepatitis are associated with non-response to corticosteroid therapy | 2.9 | 0 | Citations (PDF) |
| 146 | Bioenergetics defect of CD14+ monocytes are associated with increased mortality in acute liver failure | 2.9 | 0 | Citations (PDF) |
| 147 | Modulation of native decellularized liver matrix enhances hepatic cells proliferation, viability and functions on 3D-bioscaffolds | 2.9 | 0 | Citations (PDF) |
| 148 | Establishment of murine model of acute-on-chronic liver failure | 2.9 | 0 | Citations (PDF) |
| 149 | Incidence and risk factors for cardiovascular events in patients with advanced fibrosis due to non-alcoholic steatohepatitis: data from the phase 3 STELLAR trials | 2.9 | 0 | Citations (PDF) |
| 150 | Liver sinusoidal endothelial cell-specific RUNX-1 gene knockdown decreases hepatic inflammation and myeloid cells infiltration in pre-clinical animal models non-alcoholic steatohepatitis | 2.9 | 0 | Citations (PDF) |
| 151 | Broad defect in energy metabolism drives immune dysfunction in cirrhosis and cirrhosis associated sepsis | 2.9 | 0 | Citations (PDF) |
| 152 | Prevalence, profile and predictors of invasive fungal infections in acute-on-chronic liver failure; analysis of Asia Pacific Association for Study of the Liver, Acute-on-Chronic Liver Failure Research Consortium (AARC) data base | 2.9 | 0 | Citations (PDF) |
| 153 | Aspirin induces autophagy and alleviates liver fibrosis by reducing oxidative stress and inflammation in mice model of chronic liver injury | 2.9 | 0 | Citations (PDF) |
| 154 | Sarcopenia increases the risk of post transjuglar intrahepatic portosystemic shunt hepatic encephalopathy | 2.9 | 0 | Citations (PDF) |
| 155 | Current Concepts in Coagulation Profile in Cirrhosis and Acute‐on‐Chronic Liver Failure | 1.4 | 30 | Citations (PDF) |
| 156 | Efficacy and safety of percutaneous microwave ablation for hepatocellular carcinomas <4 cm in difficult location | 2.6 | 10 | Citations (PDF) |
| 157 | APASL practical recommendations for the management of hepatocellular carcinoma in the era of COVID-19 | 4.5 | 29 | Citations (PDF) |
| 158 | Diagnostic efficacy of dynamic liver imaging using qualitative diagnostic algorithm versus LI-RADS v2018 lexicon for atypical versus classical HCC lesions: A decade of experience from a tertiary liver institute | 2.9 | 9 | Citations (PDF) |
| 159 | Salvage Balloon Occluded Retrograde Transvenous Obliteration for Gastric Variceal Bleed in Cirrhotic Patients With Endoscopic Failure to Control Bleed/Very Early Rebleed: Long-term Outcomes | 1.0 | 9 | Citations (PDF) |
| 160 | Letter to the Editor: Cilofexor in Patients With Nonalcoholic Steatohepatitis (NASH): Is It Really Effective? | 11.6 | 2 | Citations (PDF) |
| 161 | Initial psychological impact of COVID-19 and its correlates in Indian Community: An online (FEEL-COVID) survey | 2.5 | 214 | Citations (PDF) |
| 162 | Selonsertib for patients with bridging fibrosis or compensated cirrhosis due to NASH: Results from randomized phase III STELLAR trials | 2.9 | 332 | Citations (PDF) |
| 163 | Pre-existing liver disease is associated with poor outcome in patients with SARS CoV2 infection; The APCOLIS Study (APASL COVID-19 Liver Injury Spectrum Study) | 4.5 | 215 | Citations (PDF) |
| 164 | Early Hepatocellular Carcinoma Treated by Radiofrequency Ablation—Mid- and Long-Term Outcomes | 1.0 | 14 | Citations (PDF) |
| 165 | Intractable hepatic encephalopathy in cirrhotic patients: mid-term efficacy of balloon-occluded retrograde portosystemic shunt obliteration | 3.8 | 18 | Citations (PDF) |
| 166 | Utility of N-acetylcysteine in ischemic hepatitis in cirrhotics with acute variceal bleed: a randomized controlled trial | 4.5 | 8 | Citations (PDF) |
| 167 | Salvage PTBD in post living donor liver transplant patients with biliary complications—a single centre retrospective study | 2.6 | 10 | Citations (PDF) |
| 168 | Hemodynamic Effects of Adding Simvastatin to Carvedilol for Primary Prophylaxis of Variceal Bleeding: A Randomized Controlled Trial | 0.4 | 23 | Citations (PDF) |
| 169 | "Fast, faster, and fastest: science on the run during COVID-19 drama"—"do not forget the liver" | 4.5 | 11 | Citations (PDF) |
| 170 | A new definition for metabolic dysfunction-associated fatty liver disease: An international expert consensus statement | 2.9 | 2,660 | Citations (PDF) |
| 171 | Viscoelastic test-based bleeding risk score reliably predicts coagulopathic bleeding in decompensated cirrhosis and ACLF patients | 4.5 | 10 | Citations (PDF) |
| 172 | Clinical course of COVID-19 in patients with pre-existing decompensated cirrhosis: initial report from China | 4.5 | 23 | Citations (PDF) |
| 173 | Safety and efficacy of early image-guided percutaneous interventions in acute severe necrotizing pancreatitis: A single-center retrospective study | 1.5 | 10 | Citations (PDF) |
| 174 | COVID-19 in Liver Transplant Recipients - A Series with Successful Recovery | 2.2 | 13 | Citations (PDF) |
| 175 | Predictors of steroid non-response and new approaches in severe alcoholic hepatitis | 8.3 | 12 | Citations (PDF) |
| 176 | Optimal size of Sample Pooling for RNA Pool Testing: An Avant-Garde for Scaling up Severe Acute Respiratory Syndrome Coronavirus-2 Testing | 1.1 | 11 | Citations (PDF) |
| 177 | Cloning of human ABCB11 gene in E. coli required the removal of an intragenic Pribnow-Schaller Box before it’s Insertion into genomic safe harbor AAVS1 site using CRISPR–Cas9 | 0.6 | 1 | Citations (PDF) |
| 178 | Drug-Induced Acute and Acute on Chronic Liver Failure 2020, , 219-232 | | 0 | Citations (PDF) |
| 179 | Acute-on-Chronic Liver Failure 2020, , 525-537 | | 0 | Citations (PDF) |
| 180 | A/H1N1/09 Influenza is Associated With High Mortality in Liver Cirrhosis | 1.0 | 33 | Citations (PDF) |
| 181 | Early cirrhosis and a preserved bone marrow niche favour regenerative response to growth factors in decompensated cirrhosis | 4.2 | 24 | Citations (PDF) |
| 182 | FRI-311-Gut lymphatic vascular disorder associates with severity of cirrhosis in non-alcoholic fatty liver disease | 2.9 | 0 | Citations (PDF) |
| 183 | Efficacy and safety of transjugular intrahepatic portosystemic shunt in difficult‐to‐manage hydrothorax in cirrhosis | 4.2 | 22 | Citations (PDF) |
| 184 | Letter to the Editor: Tale of Two ACLF Definitions: Choices Are Getting Clearer | 11.6 | 2 | Citations (PDF) |
| 185 | Noninvasive Tests Accurately Identify Advanced Fibrosis due to NASH: Baseline Data From the STELLAR Trials | 11.6 | 218 | Citations (PDF) |
| 186 | miR‐26b‐5p helps in EpCAM+cancer stem cells maintenance via HSC71/HSPA8 and augments malignant features in HCC | 4.2 | 26 | Citations (PDF) |
| 187 | PS-163-Faecal microbiota transplantation with tenofovir is superior to tenofovir alone in improving clinical outcomes in acute-on-chronic liver failure due to hepatitis B: An open label randomized controlled trial (NCT02689245) | 2.9 | 3 | Citations (PDF) |
| 188 | THU-275-Blood transcript modules differentiate steroid responders from non-responders at baseline in severe alcoholic hepatitis | 2.9 | 0 | Citations (PDF) |
| 189 | Noncirrhotic Portal Hypertension | 3.6 | 38 | Citations (PDF) |
| 190 | Complications constitute a major risk factor for mortality in hepatitis B virus-related acute-on-chronic liver failure patients: a multi-national study from the Asia–Pacific region | 4.5 | 44 | Citations (PDF) |
| 191 | Cellular and functional loss of liver endothelial cells correlates with poor hepatocyte regeneration in acute-on-chronic liver failure | 4.5 | 28 | Citations (PDF) |
| 192 | APASL HCV guidelines of virus-eradicated patients by DAA on how to monitor HCC occurrence and HBV reactivation | 4.5 | 76 | Citations (PDF) |
| 193 | Efficacy of Granulocyte Colony‐stimulating Factor in the Management of Steroid‐Nonresponsive Severe Alcoholic Hepatitis: A Double‐Blind Randomized Controlled Trial | 11.6 | 74 | Citations (PDF) |
| 194 | Reply: | 11.6 | 0 | Citations (PDF) |
| 195 | Acute-on-chronic liver failure: consensus recommendations of the Asian Pacific association for the study of the liver (APASL): an update | 4.5 | 563 | Citations (PDF) |
| 196 | SAT-395-Bone marrow-mesenchymal stem cells of cirrhosis patients show insulin resistance and bioenergetic exhaustion | 2.9 | 1 | Citations (PDF) |
| 197 | Maternal Immunity Influences Vertical Transmission of Hepatitis B to Newborns | 4.9 | 12 | Citations (PDF) |
| 198 | Living Donor Liver Transplantation for Acute Liver Failure: Donor Safety and Recipient Outcome | 2.8 | 52 | Citations (PDF) |
| 199 | Reply: | 11.6 | 0 | Citations (PDF) |
| 200 | Senescent Hepatocytes in Decompensated Liver Show Reduced UPRMT and Its Key Player, CLPP, Attenuates Senescence In Vitro | 6.1 | 31 | Citations (PDF) |
| 201 | Sofosbuvir–velpatasvir single-tablet regimen administered for 12 weeks in a phase 3 study with minimal monitoring in India | 4.5 | 16 | Citations (PDF) |
| 202 | Epidemiology and Effects of Bacterial Infections in Patients With Cirrhosis Worldwide | 1.0 | 348 | Citations (PDF) |
| 203 | Reply | 11.6 | 5 | Citations (PDF) |
| 204 | Dysregulated Lipid Transport Proteins Correlate With Pathogenesis and Outcome in Severe Alcoholic Hepatitis | 4.9 | 6 | Citations (PDF) |
| 205 | <p>Lower Rates Of Naturally Occurring Resistance-Associated Substitutions (RASs) In Hepatitis C Virus (HCV)-Infected Chronic Kidney Disease (CKD) Patients Than In HCV-Infected Patients With Only Liver Disease</p> | 2.6 | 1 | Citations (PDF) |
| 206 | Extracellular vesicles from hepatitis B patients serve as reservoir of hepatitis B virus <scp>DNA</scp> | 2.1 | 24 | Citations (PDF) |
| 207 | Positive familial history for metabolic traits predisposes to early and more severe alcoholic cirrhosis: A cross‐sectional study | 4.2 | 5 | Citations (PDF) |
| 208 | A double‐blind randomized controlled trial to assess efficacy of bromocriptine in cirrhotic patients with hepatic parkinsonism | 4.2 | 6 | Citations (PDF) |
| 209 | Range of Normal Liver Stiffness and Factors Associated With Increased Stiffness Measurements in Apparently Healthy Individuals | 6.4 | 64 | Citations (PDF) |
| 210 | Coagulation failure is associated with bleeding events and clinical outcome during systemic inflammatory response and sepsis in acute‐on‐chronic liver failure: An observational cohort study | 4.2 | 61 | Citations (PDF) |
| 211 | Microbiome as a therapeutic target in alcohol-related liver disease | 2.9 | 191 | Citations (PDF) |
| 212 | Correlation of baseline Portal pressure (hepatic venous pressure gradient) and Indocyanine Green Clearance Test With Post-transarterial Chemoembolization Acute Hepatic Failure | 1.0 | 6 | Citations (PDF) |
| 213 | Increased interleukin‐23 receptor (<scp>IL</scp>‐23R) expression is associated with disease severity in acute‐on‐chronic liver failure | 4.2 | 18 | Citations (PDF) |
| 214 | Modification Patterns of Urinary Albumin Correlates With Serum Albumin and Outcome in Severe Alcoholic Hepatitis | 2.5 | 11 | Citations (PDF) |
| 215 | Case Control Study of Post-endoscopic Variceal Ligation Bleeding Ulcers in Severe Liver Disease: Outcomes and Management | 2.2 | 5 | Citations (PDF) |
| 216 | Effects of zolpidem on sleep parameters in patients with cirrhosis and sleep disturbances: A randomized, placebo-controlled trial | 8.3 | 27 | Citations (PDF) |
| 217 | Outcome of conventional transarterial chemoembolization (cTACE) in the management of spontaneously ruptured hepatocellular carcinoma | 0.8 | 7 | Citations (PDF) |
| 218 | Early experience of combination therapy of transarterial chemoembolization and radiofrequency ablation for hepatocellular carcinoma measuring 3–7 cm | 0.8 | 6 | Citations (PDF) |
| 219 | A randomized open label trial of tenofovir monotherapy versus tenofovir plus telbivudine in spontaneous reactivation of hepatitis B | 1.7 | 4 | Citations (PDF) |
| 220 | Characterization of liver specific promoters in a foamy viral vector pMD09 | 0.7 | 4 | Citations (PDF) |
| 221 | Spectrum, Manifestations and Outcomes of Dengue Infection in Individuals with and without Liver Disease | 2.2 | 14 | Citations (PDF) |
| 222 | Solitary Duodenal Metastasis from Renal Cell Carcinoma with Metachronous Pancreatic Neuroendocrine Tumor: Review of Literature with a Case Discussion | 0.5 | 0 | Citations (PDF) |
| 223 | Idiopathic portal hypertension and extrahepatic portal venous obstruction | 4.5 | 56 | Citations (PDF) |
| 224 | Histological activity score on baseline liver biopsy can predict non-response to steroids in patients with severe alcoholic hepatitis | 2.7 | 23 | Citations (PDF) |
| 225 | Microvesicles in hepatic and peripheral vein can predict nonresponse to corticosteroid therapy in severe alcoholic hepatitis | 4.0 | 29 | Citations (PDF) |
| 226 | Generic sofosbuvir‐based direct‐acting antivirals in hepatitis C virus‐infected patients with chronic kidney disease | 4.2 | 27 | Citations (PDF) |
| 227 | Baseline urine metabolic phenotype in patients with severe alcoholic hepatitis and its association with outcome | 4.9 | 10 | Citations (PDF) |
| 228 | Spectrum of histopathological changes in patients with non-cirrhotic portal fibrosis | 4.5 | 18 | Citations (PDF) |
| 229 | Impact of controlled attenuation parameter on detecting fibrosis using liver stiffness measurement | 4.0 | 44 | Citations (PDF) |
| 230 | More Than Meets the Eye in Using Interleukin 6 as a Marker of Inflammation and Prognostic Factor for Patients With Cirrhosis | 6.4 | 1 | Citations (PDF) |
| 231 | Molecular Ellipticity of Circulating Albumin-Bilirubin Complex Associates With Mortality in Patients With Severe Alcoholic Hepatitis | 6.4 | 7 | Citations (PDF) |
| 232 | Higher efficacy of pegylated interferon‐α2b add‐on therapy in hepatitis B envelope antigen‐positive chronic hepatitis B patients on tenofovir monotherapy | 3.2 | 11 | Citations (PDF) |
| 233 | Placental expression of asialoglycoprotein receptor associated with Hepatitis B virus transmission from mother to child | 4.2 | 16 | Citations (PDF) |
| 234 | Extrahepatic Portal Vein Obstruction: Asian and Global Perspective 2018, , 271-300 | | 0 | Citations (PDF) |
| 235 | Anatomic Recanalization of Hepatic Vein and Inferior Vena Cava versus Direct Intrahepatic Portosystemic Shunt Creation in Budd-Chiari Syndrome: Overall Outcome and Midterm Transplant-Free Survival | 0.7 | 27 | Citations (PDF) |
| 236 | Adequate platelet counts in cirrhosis for laboratory-based optimum platelet functions | 1.8 | 1 | Citations (PDF) |
| 237 | Combined Fluoroscopy and Ultrasound-Guided Transjugular Kidney Biopsy in Cirrhotic Patients | 0.7 | 6 | Citations (PDF) |
| 238 | Immune correlates of hepatitis B surface antigen spontaneous seroconversion in hepatitis B e antigen negative chronic hepatitis B patients | 4.2 | 22 | Citations (PDF) |
| 239 | Cystatin C predicts acute kidney injury and mortality in cirrhotics: A prospective cohort study | 4.2 | 61 | Citations (PDF) |
| 240 | Global microRNA expression profiling in the liver biopsies of hepatitis B virus–infected patients suggests specific microRNA signatures for viral persistence and hepatocellular injury | 11.6 | 73 | Citations (PDF) |
| 241 | Decellularized Liver Matrix-Modified Cryogel Scaffolds as Potential Hepatocyte Carriers in Bioartificial Liver Support Systems and Implantable Liver Constructs | 8.1 | 61 | Citations (PDF) |
| 242 | Efficacy and safety of ultrasound guided percutaneous glue embolization in iatrogenic haemorrhagic complications of paracentesis and thoracocentesis in cirrhotic patients | 2.6 | 9 | Citations (PDF) |
| 243 | Budd–Chiari syndrome: a focussed and collaborative approach | 4.5 | 15 | Citations (PDF) |
| 244 | Endoscopic drainage of obstructed biliary system in altered gastrointestinal anatomy: An experience from a tertiary center in India | 1.5 | 4 | Citations (PDF) |
| 245 | Emerging non-invasive approaches for diagnosis and monitoring of portal hypertension | 22.9 | 108 | Citations (PDF) |
| 246 | Novel association of <i>Streptococcus gallolyticus subspecies pasteurianus</i> and hepatocelluar carcinoma: opening new frontiers | 1.8 | 7 | Citations (PDF) |
| 247 | Study of Family Clustering and PNPLA3 Gene Polymorphism in Pediatric Non Alcoholic Fatty Liver Disease | 0.7 | 10 | Citations (PDF) |
| 248 | Reply | 11.6 | 2 | Citations (PDF) |
| 249 | A Validated Score Predicts Acute Kidney Injury and Survival in Patients With Alcoholic Hepatitis | 2.8 | 45 | Citations (PDF) |
| 250 | Circulating Endothelial Progenitor Cells Present an Inflammatory Phenotype and Function in Patients With Alcoholic Liver Cirrhosis | 3.0 | 15 | Citations (PDF) |
| 251 | Iron-Overload triggers ADAM-17 mediated inflammation in Severe Alcoholic Hepatitis | 3.7 | 33 | Citations (PDF) |
| 252 | Early Liver Transplantation is a Viable Treatment Option in Severe Acute Alcoholic Hepatitis | 1.9 | 14 | Citations (PDF) |
| 253 | Management of acute-on-chronic liver failure: an algorithmic approach | 4.5 | 33 | Citations (PDF) |
| 254 | APASL clinical practice recommendation: how to treat HCV-infected patients with renal impairment? | 4.5 | 26 | Citations (PDF) |
| 255 | False-positive 18F fluorodeoxyglucose positron emission tomography-avid benign hepatic tumor: Previously unreported in a male patient | 0.8 | 2 | Citations (PDF) |
| 256 | Evaluation of impact of occult hepatitis B infection in chronic HCV-infected patients: A retrospective cohort study | 1.0 | 5 | Citations (PDF) |
| 257 | Role of microRNA in acute cellular rejection | 11.6 | 0 | Citations (PDF) |
| 258 | Safety and Efficacy of Sodium Tetradecyl Sulfate and Lipiodol Foam in Balloon-Occluded Retrograde Transvenous Obliteration (BRTO) for Large Porto-Systemic Shunts | 1.8 | 18 | Citations (PDF) |
| 259 | Prometheus Versus Plasma Exchange — A Comparison Of Efficiency Of Two Different Modalities Of Liver Detoxification In Patients With Acute On Chronic Liver Failure | 1.0 | 1 | Citations (PDF) |
| 260 | Impact of family history of metabolic traits on severity of non‐alcoholic steatohepatitis related cirrhosis: A cross‐sectional study | 4.2 | 18 | Citations (PDF) |
| 261 | Reply | 1.0 | 0 | Citations (PDF) |
| 262 | Changes in cardiac output and incidence of volume overload in cirrhotics receiving 20% albumin infusion | 4.2 | 19 | Citations (PDF) |
| 263 | Point -of -care testing (POCT) in molecular diagnostics: Performance evaluation of GeneXpert HCV RNA test in diagnosing and monitoring of HCV infection | 3.1 | 53 | Citations (PDF) |
| 264 | EpCAM+ Liver Cancer Stem-Like Cells Exhibiting Autocrine Wnt Signaling Potentially Originate in Cirrhotic Patients | 3.6 | 32 | Citations (PDF) |
| 265 | Carvedilol delays the progression of small oesophageal varices in patients with cirrhosis: a randomised placebo-controlled trial | 14.8 | 74 | Citations (PDF) |
| 266 | Changes in Liver Congestion in Patients with Budd–Chiari Syndrome following Endovascular Interventions: Assessment with Transient Elastography | 0.7 | 42 | Citations (PDF) |
| 267 | Development of predisposition, injury, response, organ failure model for predicting acute kidney injury in acute on chronic liver failure | 4.2 | 26 | Citations (PDF) |
| 268 | miRNA signatures can predict acute liver failure in hepatitis E infected pregnant females | 3.6 | 18 | Citations (PDF) |
| 269 | Exogenous growth factor based regenerative therapy in alcoholic cirrhosis patients renders limited effect on hemostatic elements | 1.8 | 0 | Citations (PDF) |
| 270 | Asia–Pacific clinical practice guidelines on the management of hepatocellular carcinoma: a 2017 update | 4.5 | 1,628 | Citations (PDF) |
| 271 | Clinical Features, Incidence of Hepatic Encephalopathy and Bacteriological Profile of Adult Acute Liver Failure: A Single Centre Prospective Cohort Study | 1.0 | 0 | Citations (PDF) |
| 272 | Bone marrow endothelial progenitor cells activate hepatic stellate cells and aggravate carbon tetrachloride induced liver fibrosis in mice via paracrine factors | 5.9 | 12 | Citations (PDF) |
| 273 | Characterization of body composition and definition of sarcopenia in patients with alcoholic cirrhosis: A computed tomography based study | 4.2 | 52 | Citations (PDF) |
| 274 | Peg-interferon plus nucleotide analogue in patients with chronic hepatitis B with low viral load | 22.9 | 1 | Citations (PDF) |
| 275 | Living Donor Liver Transplantation for Acute Liver Failure With Fixed Pupils: Are We Fixed? | 1.0 | 1 | Citations (PDF) |
| 276 | Hyperoxidized albumin modulates neutrophils to induce oxidative stress and inflammation in severe alcoholic hepatitis | 11.6 | 85 | Citations (PDF) |
| 277 | Randomized controlled trial comparing lactulose plus albumin <i>versus</i> lactulose alone for treatment of hepatic encephalopathy | 2.8 | 57 | Citations (PDF) |
| 278 | Primary Hepatic Amyloidosis Presenting as Acute-on-Chronic Liver Failure | 0.5 | 7 | Citations (PDF) |
| 279 | Infections in Live Donor Liver Transplant Recipients: A Study of Timeline, Aetiology and Antimicrobial Resistance of Bacterial and Fungal Infections from the Developing World | 1.1 | 7 | Citations (PDF) |
| 280 | Blockade of Neutrophil’s Chemokine Receptors CXCR1/2 Abrogate Liver Damage in Acute-on-Chronic Liver Failure | 5.0 | 57 | Citations (PDF) |
| 281 | The imbalance of procoagulant and anticoagulant factors in patients with chronic liver diseases in North India | 1.9 | 0 | Citations (PDF) |
| 282 | Deceased donor liver transplant: Experience from a public sector hospital in India | 1.5 | 7 | Citations (PDF) |
| 283 | SX-Ella Stent Danis Effectively Controls Refractory Variceal Bleed in Patients with Acute-on-Chronic Liver Failure | 2.2 | 13 | Citations (PDF) |
| 284 | AKI persistence at 48 h predicts mortality in patients with acute on chronic liver failure | 4.5 | 14 | Citations (PDF) |
| 285 | An RNAi-based high-throughput screening assay to identify small molecule inhibitors of hepatitis B virus replication | 2.3 | 12 | Citations (PDF) |
| 286 | EUS-guided Gall Bladder Drainage in Severe Liver Disease: A Single-center Experience in Critically Ill Cirrhotics | 2.2 | 5 | Citations (PDF) |
| 287 | Radiofrequency ablation of surface v/s intraparenchymal hepatocellular carcinoma in cirrhotic patients | 0.8 | 8 | Citations (PDF) |
| 288 | New treatment options for alcoholic hepatitis | 4.7 | 18 | Citations (PDF) |
| 289 | Primary prophylaxis of variceal bleeding in children and the role of MesoRex Bypass: Summary of the Baveno VI Pediatric Satellite Symposium | 11.6 | 117 | Citations (PDF) |
| 290 | Serial changes of cytokines and growth factors in peripheral circulation after right lobe donor hepatectomy | 2.8 | 16 | Citations (PDF) |
| 291 | APASL consensus statements and recommendations for hepatitis C prevention, epidemiology, and laboratory testing | 4.5 | 75 | Citations (PDF) |
| 292 | Elevated hepatic lipid and interferon stimulated gene expression in HCV GT3 patients relative to non-alcoholic steatohepatitis | 4.5 | 15 | Citations (PDF) |
| 293 | APASL consensus statements and recommendation on treatment of hepatitis C | 4.5 | 188 | Citations (PDF) |
| 294 | Terlipressin Reduces Mortality in Hepatorenal Syndrome 2016, , 121-132 | | 0 | Citations (PDF) |
| 295 | Role of dual energy spectral computed tomography in characterization of hepatocellular carcinoma: Initial experience from a tertiary liver care institute | 2.9 | 26 | Citations (PDF) |
| 296 | Use of a Roth Net Platinum Universal Retriever for the endoscopic management of a large symptomatic gallstone causing Bouveret’s syndrome | 3.5 | 4 | Citations (PDF) |
| 297 | Functionally aberrant dendritic cell subsets and expression of DC-SIGN differentiate acute from chronic HBV infection | 4.5 | 6 | Citations (PDF) |
| 298 | Toward a Comprehensive New Classification of Portal Vein Thrombosis in Patients With Cirrhosis | 1.0 | 131 | Citations (PDF) |
| 299 | Sepsis in cirrhosis: emerging concepts in pathogenesis, diagnosis and management | 4.5 | 12 | Citations (PDF) |
| 300 | The Intensiveness of Intensive Enteral Nutrition Therapy | 1.0 | 1 | Citations (PDF) |
| 301 | Reviewing the diagnostic criteria for acute-on-chronic liver failure | 2.4 | 10 | Citations (PDF) |
| 302 | Acute-on-chronic Liver Failure | 2.8 | 29 | Citations (PDF) |
| 303 | Prevalence and prognostic significance of hyperkalemia in hospitalized patients with cirrhosis | 2.8 | 21 | Citations (PDF) |
| 304 | Increased CD56bright NK cells in HIV-HCV co-infection and HCV mono-infection are associated with distinctive alterations of their phenotype | 3.7 | 8 | Citations (PDF) |
| 305 | Quantitative fibrosis estimation by image analysis predicts development of decompensation, composite events and defines event-free survival in chronic hepatitis B patients | 2.4 | 13 | Citations (PDF) |
| 306 | Correlates of disease-specific knowledge among patients with chronic hepatitis B or hepatitis C infection in India | 4.5 | 7 | Citations (PDF) |
| 307 | Response to Treatment of spontaneous bacterial peritonitis: beyond the current international guidelines | 4.2 | 1 | Citations (PDF) |
| 308 | Selection and outcome of the potential live liver donor | 4.5 | 32 | Citations (PDF) |
| 309 | Acute-on-chronic liver failure: terminology, mechanisms and management | 14.7 | 273 | Citations (PDF) |
| 310 | Repurposing of metformin in liver injury: The JNK conundrum | 2.9 | 1 | Citations (PDF) |
| 311 | Asian-Pacific Association for the Study of the Liver (APASL) consensus guidelines on invasive and non-invasive assessment of hepatic fibrosis: a 2016 update | 4.5 | 187 | Citations (PDF) |
| 312 | Malignant Retroperitoneal Extra-Gastrointestinal Stromal Tumor: A Unique Entity | 1.6 | 11 | Citations (PDF) |
| 313 | Strongyloides stercoralis hyperinfection in patient with autoimmune hepatitis and purpura fulminans | 0.9 | 8 | Citations (PDF) |
| 314 | Hepatic visceral larva migrans, a resilient entity on imaging: Experience from a tertiary liver center | 0.6 | 11 | Citations (PDF) |
| 315 | Extrahepatic Portal Vein Obstruction (EHPVO) and Idiopathic Portal Hypertension: East Versus West 2016, , 377-395 | | 0 | Citations (PDF) |
| 316 | Impaired monocyte‐macrophage functions and defective toll‐like receptor signaling in hepatitis E virus‐infected pregnant women with acute liver failure | 11.6 | 57 | Citations (PDF) |
| 317 | Cirrhotic patients with large esophageal varices and older age have poor hemodynamic response to terlipressin | 1.4 | 1 | Citations (PDF) |
| 318 | New approaches for cholestasis in hemoglobinopathies | 1.9 | 0 | Citations (PDF) |
| 319 | Definition of ACLF and inclusion criteria for extra-hepatic organ failure | 4.5 | 17 | Citations (PDF) |
| 320 | Role of non-hepatotropic viruses in acute sporadic viral hepatitis and acute-on-chronic liver failure in adults | 1.5 | 30 | Citations (PDF) |
| 321 | Spectrum of hepatofugal collateral pathways in portal hypertension: an illustrated radiological review | 4.1 | 38 | Citations (PDF) |
| 322 | Multimodality imaging of obliterative portal venopathy: what every radiologist should know | 2.6 | 22 | Citations (PDF) |
| 323 | Diagnosis and management of acute kidney injury in patients with cirrhosis: revised consensus recommendations of the International Club of Ascites | 14.8 | 436 | Citations (PDF) |
| 324 | Reply to: “Ferritin in decompensated cirrhosis: Iron or inflammation?” | 2.9 | 1 | Citations (PDF) |
| 325 | Diagnosis and management of acute kidney injury in patients with cirrhosis: Revised consensus recommendations of the International Club of Ascites | 2.9 | 590 | Citations (PDF) |
| 326 | Dysregulated iron homeostasis is strongly associated with multiorgan failure and early mortality in acute‐on‐chronic liver failure | 11.6 | 66 | Citations (PDF) |
| 327 | Multimodality imaging of primary extrahepatic portal vein obstruction (EHPVO): what every radiologist should know | 2.6 | 31 | Citations (PDF) |
| 328 | CD4+CD25+CD127low Regulatory T Cells Play Predominant Anti-Tumor Suppressive Role in Hepatitis B Virus-Associated Hepatocellular Carcinoma | 5.0 | 33 | Citations (PDF) |
| 329 | Correlation between two chemiluminescence based assays for quantification of hepatitis B surface antigen in patients with chronic hepatitis B infection | 1.1 | 5 | Citations (PDF) |
| 330 | Combination of Granulocyte Colony-Stimulating Factor and Erythropoietin Improves Outcomes of Patients With Decompensated Cirrhosis | 1.0 | 115 | Citations (PDF) |
| 331 | Hepatobiliary IgG4 Cholangiopathy | 1.0 | 4 | Citations (PDF) |
| 332 | Inflammatory Myofibroblastic Tumor of Liver Masquerading as Focal Nodular Hyperplasia in a Patient with Non-Cirrhotic Portal Hypertension and Biliary Pancreatitis | 0.5 | 3 | Citations (PDF) |
| 333 | Acute kidney injury in acute on chronic liver failure | 4.5 | 31 | Citations (PDF) |
| 334 | SIRS at Admission Is a Predictor of AKI Development and Mortality in Hospitalized Patients with Severe Alcoholic Hepatitis | 2.2 | 42 | Citations (PDF) |
| 335 | Primary Hepatic Non-Hodgkin’s Lymphoma: An Enigma Beyond the Liver, a Case Report | 1.6 | 4 | Citations (PDF) |
| 336 | Angiosarcoma of the Liver: Imaging of a rare salient entity | 0.7 | 19 | Citations (PDF) |
| 337 | Antitubercular therapy in patients with cirrhosis: Challenges and options | 4.7 | 31 | Citations (PDF) |
| 338 | Population Pharmacokinetics and Pharmacodynamics of Albinterferon Alfa-2b in Patients Treated for Hepatitis C Virus Genotype 2/3 | 0.6 | 1 | Citations (PDF) |
| 339 | Acute-on-chronic liver failure: consensus recommendations of the Asian Pacific Association for the Study of the Liver (APASL) 2014 | 4.5 | 853 | Citations (PDF) |
| 340 | Simultaneous Occurrence of Ocular, Disseminated Mucocutaneous, and Multivisceral Involvement of Leishmaniasis | 0.5 | 8 | Citations (PDF) |
| 341 | Spontaneous cryptococcal peritonitis with fungemia in patients with decompensated cirrhosis: Report of two cases | 0.9 | 12 | Citations (PDF) |
| 342 | Reply to: “Low free T3 levels are related to early mortality in patients with decompensated cirrhosis and acute-on chronic liver failure” | 2.9 | 0 | Citations (PDF) |
| 343 | Platelets contribute in hepatocellular carcinoma metastasis? | 1.8 | 1 | Citations (PDF) |
| 344 | Diagnostic dilemmas in human immunodeficiency virus testing | 0.3 | 1 | Citations (PDF) |
| 345 | How to Manage Gastric and Ectopic Varices? 2014, , 171-201 | | 1 | Citations (PDF) |
| 346 | Correlation of aspartate aminotransferase/platelet ratio index with hepatic venous pressure gradient in cirrhosis | 5.2 | 29 | Citations (PDF) |
| 347 | World Gastroenterology Organisation Global Guidelines | 2.5 | 321 | Citations (PDF) |
| 348 | Parvovirus B19 associated acute hepatitis and hepatosplenomegaly | 1.8 | 3 | Citations (PDF) |
| 349 | Non-cirrhotic portal hypertension – Diagnosis and management | 2.9 | 319 | Citations (PDF) |
| 350 | Paraduodenal pancreatitis | 1.1 | 32 | Citations (PDF) |
| 351 | Identification of Indian sub-continent as hotspot for HCV genotype 3a origin by Bayesian evolutionary reconstruction | 2.4 | 13 | Citations (PDF) |
| 352 | Endoscopic Treatment of Gastric Varices | 3.6 | 32 | Citations (PDF) |
| 353 | Two-tier regenerative response in liver failure in humans | 2.7 | 16 | Citations (PDF) |
| 354 | Growth factors enhance liver regeneration in acute-on-chronic liver failure | 4.5 | 8 | Citations (PDF) |
| 355 | Influenza A/H1/N1/09 infection in patients with cirrhosis has a poor outcome: A case series | 1.5 | 8 | Citations (PDF) |
| 356 | Non-cirrhotic Portal Hypertension | 3.6 | 75 | Citations (PDF) |
| 357 | Liver dialysis in acute-on-chronic liver failure: current and future perspectives | 4.5 | 21 | Citations (PDF) |
| 358 | Procoagulant abnormalities in cirrhosis with portal vein thrombosis | 1.5 | 0 | Citations (PDF) |
| 359 | Hepatitis B Virus Induces Cell Proliferation via HBx-Induced microRNA-21 in Hepatocellular Carcinoma by Targeting Programmed Cell Death Protein4 (PDCD4) and Phosphatase and Tensin Homologue (PTEN) | 2.5 | 75 | Citations (PDF) |
| 360 | Potent antiviral therapy improves survival in acute on chronic liver failure due to hepatitis B virus reactivation | 4.7 | 28 | Citations (PDF) |
| 361 | Hepatocellular carcinoma presenting with multiple bone and soft tissue metastases and atypical cytomorphological features—A rare case report | 1.1 | 7 | Citations (PDF) |
| 362 | Etiology and prognostic factors of acute liver failure in children | 0.7 | 52 | Citations (PDF) |
| 363 | Management of acute kidney injury in cirrhosis | 4.5 | 6 | Citations (PDF) |
| 364 | Role of hepatitis E virus antigen in confirming active viral replication in patients with acute viral hepatitis E infection | 3.1 | 37 | Citations (PDF) |
| 365 | Liver Regeneration During Acute-on-Chronic Liver Failure Using Growth Factors: In Vivo or Ex Vivo Indulgence of Bone Marrow? | 1.0 | 6 | Citations (PDF) |
| 366 | Predictors and outcomes of liver failure in severe hepatitis B reactivation | 1.0 | 1 | Citations (PDF) |
| 367 | A randomised double blind controlled trial comparing rifaximin plus lactulose with lactulose alone in treatment of hepatic encephalopathy | 1.0 | 1 | Citations (PDF) |
| 368 | Contrast-enhanced US-guided Radiofrequency Ablation of Hepatocellular Carcinoma | 0.7 | 28 | Citations (PDF) |
| 369 | Genetic polymorphisms of CYP2E1 and DNA repair genes HOGG1 and XRCC1: Association with hepatitis B related advanced liver disease and cancer | 2.4 | 30 | Citations (PDF) |
| 370 | Acute-on-chronic liver failure–Does etiology really matter? | 1.0 | 1 | Citations (PDF) |
| 371 | Clinicopathological characteristics and metabolic profiles of non-alcoholic fatty liver disease in Indian patients with normal body mass index: Do they differ from obese or overweight non-alcoholic fatty liver disease? | 0.4 | 95 | Citations (PDF) |
| 372 | Sonoclot Signature Analysis in Patients with Liver Disease and Its Correlation with Conventional Coagulation Studies | 1.5 | 28 | Citations (PDF) |
| 373 | Hepatitis E- Is it a risk to transfusion safety? | 0.3 | 12 | Citations (PDF) |
| 374 | Deeper insights into the relevance of lymphatic circulation in cirrhosis of the liver: A trojan horse or the holy grail? | 11.6 | 2 | Citations (PDF) |
| 375 | Augmentation of Hepatitis B Virus-Specific Cellular Immunity with Programmed Death Receptor-1/Programmed Death Receptor-L1 Blockade in Hepatitis B Virus and HIV/Hepatitis B Virus Coinfected Patients Treated with Adefovir | 1.5 | 23 | Citations (PDF) |
| 376 | Cirrhosis histology and Laennec staging system correlate with high portal pressure | 3.9 | 41 | Citations (PDF) |
| 377 | Hepatic and systemic hemodynamic derangements predict early mortality and recovery in patients with acute‐on‐chronic liver failure | 2.8 | 48 | Citations (PDF) |
| 378 | Decline in Immature Transitional B Cells After Hepatitis B Vaccination in Hepatitis B Positive Newborns | 1.3 | 5 | Citations (PDF) |
| 379 | Expression of inhibitory markers is increased on effector memory T cells during hepatitis C virus/HIV coinfection as compared to hepatitis C virus or HIV monoinfectionAids, 2013, 27, 2191-2200 | 2.6 | 21 | Citations (PDF) |
| 380 | Contrast ultrasound in hepatocellular carcinoma at a tertiary liver center: First Indian experience | 1.3 | 3 | Citations (PDF) |
| 381 | Analysis of Notch and TGF-β Signaling Expression in Different Stages of Disease Progression During Hepatitis B Virus Infection | 3.0 | 23 | Citations (PDF) |
| 382 | Adding variceal status to Child–Turcotte–Pugh score improves its performance in predicting early mortality in cirrhosis | 1.4 | 5 | Citations (PDF) |
| 383 | Addition of probiotics to norfloxacin does not improve efficacy in the prevention of spontaneous bacterial peritonitis | 1.4 | 43 | Citations (PDF) |
| 384 | Randomized controlled trial for endoscopy with propofol versus midazolam on psychometric tests and critical flicker frequency in people with cirrhosis | 2.8 | 19 | Citations (PDF) |
| 385 | Ectopic varices | 1.4 | 42 | Citations (PDF) |
| 386 | Hepatic stellate cells are involved in the pathogenesis of acute-on-chronic liver failure (ACLF) | 2.7 | 22 | Citations (PDF) |
| 387 | Unconjugated hyperbilirubinemia in patients with non-alcoholic fatty liver disease: A favorable endogenous response | 1.8 | 30 | Citations (PDF) |
| 388 | Prevalence of hepatitis C virus in a selected geographical area of northern India: a population based survey | 1.5 | 42 | Citations (PDF) |
| 389 | Increased number and function of endothelial progenitor cells stimulate angiogenesis by resident liver sinusoidal endothelial cells (SECs) in cirrhosis through paracrine factors | 2.9 | 34 | Citations (PDF) |
| 390 | Mo1841 Interleukin-28b TT Genotype Predicts Treatment Non-Responsiveness in Genotype 3 Indian HCV Patients | 1.0 | 0 | Citations (PDF) |
| 391 | Diagnostic Spectrum and Accuracy of Endoscopic Ultrasound-Guided Fine Needle Aspiration from Pancreatic and Peripancreatic Lesions: An Experience of a Single Tertiary Care Center from India | 0.7 | 0 | Citations (PDF) |
| 392 | Efficacy of Balloon-occluded Retrograde Transvenous Obliteration of Large Spontaneous Lienorenal Shunt in Patients with Severe Recurrent Hepatic Encephalopathy with Foam Sclerotherapy: Initial Experience | 0.7 | 63 | Citations (PDF) |
| 393 | Liver and Spleen Stiffness in Patients with Extrahepatic Portal Vein Obstruction | 9.6 | 58 | Citations (PDF) |
| 394 | Association of adiponectin gene functional polymorphisms (− 11377C/G and + 45T/G) with nonalcoholic fatty liver disease | 2.4 | 36 | Citations (PDF) |
| 395 | Does reference value of “Normal Liver Stiffness” using fibroscan have a regional variation? | 11.6 | 1 | Citations (PDF) |
| 396 | Granulocyte Colony–Stimulating Factor Mobilizes CD34+ Cells and Improves Survival of Patients With Acute-on-Chronic Liver Failure | 1.0 | 318 | Citations (PDF) |
| 397 | Predictive Scores for Hepatocellular Carcinoma Development in Chronic Hepatitis B Virus Infection: “Does One Size Fit All?” | 1.0 | 6 | Citations (PDF) |
| 398 | A Randomized Controlled Trial Comparing Efficacy of Pentoxifylline and Pioglitazone on Metabolic Factors and Liver Histology in Patients with Non-alcoholic Steatohepatitis | 1.0 | 34 | Citations (PDF) |
| 399 | Clinical profile and predictors of mortality in patients of acute-on-chronic liver failure | 1.3 | 150 | Citations (PDF) |
| 400 | Serum endotoxin and inflammatory mediators in patients with cirrhosis and hepatic encephalopathy | 1.3 | 48 | Citations (PDF) |
| 401 | Natural history of HCV infection | 4.5 | 19 | Citations (PDF) |
| 402 | APASL consensus statements and management algorithms for hepatitis C virus infection | 4.5 | 144 | Citations (PDF) |
| 403 | Primary prophylaxis of overt hepatic encephalopathy in patients with cirrhosis: An open labeled randomized controlled trial of lactulose <i>versus</i> no lactulose | 2.8 | 99 | Citations (PDF) |
| 404 | Nitric oxide and prostaglandin as mediators in the pathogenesis of hyperkinetic circulatory state in a model of endotoxemia-induced portal hypertension | 4.5 | 3 | Citations (PDF) |
| 405 | Paradigms in the management of hepatic hydrothorax: past, present, and future | 4.5 | 5 | Citations (PDF) |
| 406 | Early primary prophylaxis with beta-blockers does not prevent the growth of small esophageal varices in cirrhosis: a randomized controlled trial | 4.5 | 36 | Citations (PDF) |
| 407 | Extensive Amyloid Deposit in Bone Marrow Aspirate | 0.4 | 4 | Citations (PDF) |
| 408 | Liver Stiffness Measurements in Patients with Different Stages of Nonalcoholic Fatty Liver Disease: Diagnostic Performance and Clinicopathological Correlation | 2.2 | 93 | Citations (PDF) |
| 409 | Disaccharides in the Treatment of Hepatic Encephalopathy 2012, , 141-158 | | 1 | Citations (PDF) |
| 410 | Endoscopically diagnosed fistula between hepatic artery and first part of duodenum as a cause of massive upper gastrointestinal hemorrhage | 0.3 | 0 | Citations (PDF) |
| 411 | 064 LIVING WILLS-A TOOL TO PROMOTE? | 0.2 | 0 | Citations (PDF) |
| 412 | A Vaccine for Hepatitis E: Has It Finally Arrived? | 1.0 | 2 | Citations (PDF) |
| 413 | Influence of Chronic HBV Infection on Pregnancy: A Human Model of Maternofetal Virus Host Interactions | 1.0 | 10 | Citations (PDF) |
| 414 | Conservative management of liver abscess complicated by hepatogastric fistula | 1.3 | 5 | Citations (PDF) |
| 415 | Association of nonalcoholic fatty liver disease with metabolic syndrome in Indian population | 3.3 | 2 | Citations (PDF) |
| 416 | Primary prophylaxis of gastric variceal bleeding comparing cyanoacrylate injection and beta-blockers: A randomized controlled trial | 2.9 | 175 | Citations (PDF) |
| 417 | Revising consensus in portal hypertension | 2.9 | 14 | Citations (PDF) |
| 418 | Use of Stem Cells for Liver Diseases—Current Scenario | 1.0 | 8 | Citations (PDF) |
| 419 | Prevention of hepatorenal syndrome in patients with cirrhosis and ascites | 1.4 | 45 | Citations (PDF) |
| 420 | Gene Expression Profiles of T Cells from Hepatitis E Virus Infected Patients in Acute and Resolving Phase | 3.4 | 15 | Citations (PDF) |
| 421 | Circulating Tregs Correlate with Viral Load Reduction in Chronic HBV-Treated Patients with Tenofovir Disoproxil Fumarate | 3.4 | 35 | Citations (PDF) |
| 422 | Liver histology as predictor of outcome in patients with acute-on-chronic liver failure (ACLF) | 2.7 | 41 | Citations (PDF) |
| 423 | Diagnosis and management of acute variceal bleeding: Asian Pacific Association for Study of the Liver recommendations | 4.5 | 112 | Citations (PDF) |
| 424 | Prevalence, risk factors and virological profile of chronic hepatitis b virus infection in pregnant women in India | 3.8 | 46 | Citations (PDF) |
| 425 | Tenofovir improves the outcome in patients with spontaneous reactivation of hepatitis B presenting as acute-on-chronic liver failure | 11.6 | 217 | Citations (PDF) |
| 426 | Hyponatremia in patients with acute variceal bleeding treated with terlipressin | 11.6 | 5 | Citations (PDF) |
| 427 | Efficacy and safety of entecavir versus adefovir in chronic hepatitis B patients with hepatic decompensation: A randomized, open-label study | 11.6 | 175 | Citations (PDF) |
| 428 | Reply | 11.6 | 0 | Citations (PDF) |
| 429 | Factors influencing occurrence of postpartum haemorrhage in pregnant women with hepatitis E infection and deranged coagulation profile | 0.8 | 4 | Citations (PDF) |
| 430 | A randomized controlled trial comparing lactulose, probiotics, and L-ornithine L-aspartate in treatment of minimal hepatic encephalopathy | 1.4 | 178 | Citations (PDF) |
| 431 | Naturally occurring core immune-escape and carboxy-terminal mutations\truncations in patients with e antigen negative chronic hepatitis B | 4.5 | 0 | Citations (PDF) |
| 432 | Steatosis in chronic hepatitis B: Prevalence and correlation with biochemical, histologic, viral, and metabolic parameters | 0.3 | 48 | Citations (PDF) |
| 433 | Viral Hepatitis A | 0.0 | 1 | Citations (PDF) |
| 434 | Viral Hepatitis E | 0.0 | 1 | Citations (PDF) |
| 435 | Extrahepatic Portal Vein Obstruction (EHPVO) 2011, , 151-164 | | 0 | Citations (PDF) |
| 436 | Clinical, Laboratory, and Hemodynamic Parameters in Portal Hypertensive Gastropathy | 2.5 | 36 | Citations (PDF) |
| 437 | Predictors of nonresponse to lactulose in patients with cirrhosis and hepatic encephalopathy | 1.4 | 27 | Citations (PDF) |
| 438 | Asian Pacific Association for the Study of the Liver consensus recommendations on hepatocellular carcinoma | 4.5 | 856 | Citations (PDF) |
| 439 | Impaired Antigen Processing and Presentation Machinery is Associated with Immunotolerant State in Chronic Hepatitis B Virus Infection | 3.4 | 16 | Citations (PDF) |
| 440 | Endoscopic cyanoacrylate injection versus -blocker for secondary prophylaxis of gastric variceal bleed: a randomised controlled trial | 14.8 | 132 | Citations (PDF) |
| 441 | Prevalence of abnormal psychometric tests and critical flicker frequency after clinical recovery of overt hepatic encephalopathy | 0.4 | 9 | Citations (PDF) |
| 442 | Endoscopic Therapy for Gastric Varices | 3.6 | 32 | Citations (PDF) |
| 443 | Equal Efficacy of Endoscopic Variceal Ligation and Propranolol in Preventing Variceal Bleeding in Patients With Noncirrhotic Portal Hypertension | 1.0 | 76 | Citations (PDF) |
| 444 | Peroxisome proliferators-activated receptor γ2 Pro12Ala variant is associated with body mass index in non-alcoholic fatty liver disease patients | 4.5 | 23 | Citations (PDF) |
| 445 | Predictors of histological activity and fibrosis in chronic Hepatitis C infection: A study from North India | 0.3 | 7 | Citations (PDF) |
| 446 | Comparison of clinical, biochemical and histological features of alcoholic steatohepatitis and non-alcoholic steatohepatitis in Asian Indian patients | 0.3 | 12 | Citations (PDF) |
| 447 | Insulin Resistance in Chronic Hepatitis B Virus Infection | 0.4 | 30 | Citations (PDF) |
| 448 | Natural History of Minimal Hepatic Encephalopathy in Patients With Extrahepatic Portal Vein Obstruction | 0.4 | 26 | Citations (PDF) |
| 449 | Alpha-fetoprotein production by non-hepatocellular carcinoma, malignant liver tumor | 0.9 | 2 | Citations (PDF) |
| 450 | Effect of peptide pools on effector functions of antigen-specific CD8+ T cells | 1.5 | 24 | Citations (PDF) |
| 451 | Gene expression signatures of peripheral CD4+ T cells clearly discriminate between patients with acute and chronic hepatitis B infection | 11.6 | 28 | Citations (PDF) |
| 452 | Association of IL-18 promoter polymorphism with liver disease severity in HCV-infected patients | 4.5 | 25 | Citations (PDF) |
| 453 | HBV prevalence, natural history, and treatment in India and Indian Americans in the United States | 1.0 | 1 | Citations (PDF) |
| 454 | Hepatitis B virus genotypes and hepatitis B surface antigen mutations in family contacts of hepatitis B virus infected patients with occult hepatitis B virus infection | 2.8 | 31 | Citations (PDF) |
| 455 | Neuropsychological impairment in severe acute viral hepatitis is due to minimal hepatic encephalopathy | 4.2 | 5 | Citations (PDF) |
| 456 | Predictors of nonresponse to lactulose for minimal hepatic encephalopathy in patients with cirrhosis | 4.2 | 35 | Citations (PDF) |
| 457 | Infliximab monotherapy for severe alcoholic hepatitis and predictors of survival: An open label trial | 2.9 | 49 | Citations (PDF) |
| 458 | Serum adipokine profile in Indian men with nonalcoholic steatohepatitis: Serum adiponectin is paradoxically decreased in lean vs. obese patients | 3.3 | 1 | Citations (PDF) |
| 459 | Spontaneous Increases in Alanine Aminotransferase Levels in Asymptomatic Chronic Hepatitis B Virus-Infected Patients | 1.0 | 55 | Citations (PDF) |
| 460 | Addition of Propranolol and Isosorbide Mononitrate to Endoscopic Variceal Ligation Does Not Reduce Variceal Rebleeding Incidence | 1.0 | 56 | Citations (PDF) |
| 461 | Secondary Prophylaxis of Hepatic Encephalopathy: An Open-Label Randomized Controlled Trial of Lactulose Versus Placebo | 1.0 | 276 | Citations (PDF) |
| 462 | Hepatitis B Virus Immunotolerant Patients: Need to Differentiate Patients With or Without Liver Disease | 1.0 | 12 | Citations (PDF) |
| 463 | S1845 Pulmonary Vasodilation Exceeds Systemic Vasodilation But Does Not Correlate with Severity of Hepatic Dysfunction in Cirrhotics | 1.0 | 0 | Citations (PDF) |
| 464 | Epidemiology, Screening, and Natural History of Chronic Hepatitis B Infection 2009, , 185-241 | | 3 | Citations (PDF) |
| 465 | Should chronic HBV infected patients with normal ALT treated: debate | 4.5 | 23 | Citations (PDF) |
| 466 | Primary prophylaxis of gastroesophageal variceal bleeding: consensus recommendations of the Asian Pacific Association for the Study of the Liver | 4.5 | 37 | Citations (PDF) |
| 467 | Low levels of awareness, vaccine coverage, and the need for boosters among health care workers in tertiary care hospitals in India | 2.8 | 80 | Citations (PDF) |
| 468 | Virologic and Histologic Features of Chronic Hepatitis B Virus-Infected Asymptomatic Patients With Persistently Normal ALT | 1.0 | 338 | Citations (PDF) |
| 469 | Reply | 1.0 | 2 | Citations (PDF) |
| 470 | 252 High Maternal Hepatitis B Virus DNA Levels But Not HBeAg Positivity Predicts Perinatal Transmission of Hepatitis B to the Newborn | 1.0 | 8 | Citations (PDF) |
| 471 | S2082 Viral Kinetics During Adefovir in Treatment NaÏVe Chronic Hepatitis B (CHB) Patients | 1.0 | 0 | Citations (PDF) |
| 472 | Pharmacology, clinical efficacy and safety of lamivudine in hepatitis B virus infection | 2.4 | 2 | Citations (PDF) |
| 473 | An Open Label, Pilot, Randomized Controlled Trial of Noradrenaline<i>Versus</i>Terlipressin in the Treatment of Type 1 Hepatorenal Syndrome and Predictors of Response | 0.4 | 228 | Citations (PDF) |
| 474 | Characteristics of hepatocellular carcinoma in India: a retrospective analysis of 191 cases | 0.5 | 68 | Citations (PDF) |
| 475 | An open-label randomized controlled trial of lactulose and probiotics in the treatment of minimal hepatic encephalopathy | 1.4 | 147 | Citations (PDF) |
| 476 | Hemodynamic Studies in Acute-on-Chronic Liver Failure | 2.2 | 46 | Citations (PDF) |
| 477 | Acute-on-chronic liver failure: consensus recommendations of the Asian Pacific Association for the study of the liver (APASL) | 4.5 | 691 | Citations (PDF) |
| 478 | Systemic and pulmonary hemodynamics in patients with extrahepatic portal vein obstruction is similar to compensated cirrhotic patients | 4.5 | 14 | Citations (PDF) |
| 479 | Liver fibrosis: consensus recommendations of the Asian Pacific Association for the Study of the Liver (APASL) | 4.5 | 83 | Citations (PDF) |
| 480 | Identification and characterization of genotype A and D recombinant hepatitis B virus from Indian chronic HBV isolates | 4.7 | 22 | Citations (PDF) |
| 481 | Effect of Lowering HBV DNA Levels by Initial Antiviral Therapy Before Adding Immunomodulator on Treatment of Chronic Hepatitis B | 0.4 | 66 | Citations (PDF) |
| 482 | Maternal and Fetal Outcomes in Pregnant Women with Acute Hepatitis E Virus Infection | 10.5 | 340 | Citations (PDF) |
| 483 | Altered alpha adrenergic vasoresponsiveness in a non-cirrhotic portal hypertension model ofE. coliinjection | 2.8 | 7 | Citations (PDF) |
| 484 | Risk factors analysis for hepatocellular carcinoma in patients with and without cirrhosis: A case–control study of 213 hepatocellular carcinoma patients from India | 2.8 | 81 | Citations (PDF) |
| 485 | Responding to the progress in hepatology: beyond the boundaries | 4.5 | 6 | Citations (PDF) |
| 486 | Systemic and pulmonary hemodynamics in patients with non-cirrhotic portal fibrosis (NCPF) is similar to compensated cirrhosis | 4.5 | 14 | Citations (PDF) |
| 487 | Noncirrhotic portal fibrosis/idiopathic portal hypertension: APASL recommendations for diagnosis and treatment | 4.5 | 151 | Citations (PDF) |
| 488 | Independent Predictors of Steatohepatitis and Fibrosis in Asian Indian Patients with Non-Alcoholic Steatohepatitis | 2.2 | 45 | Citations (PDF) |
| 489 | Association between vitamin D receptor, CCR5, TNF-α and TNF-β gene polymorphisms and HBV infection and severity of liver disease | 2.9 | 97 | Citations (PDF) |
| 490 | Noncirrhotic Portal Hypertension | 3.6 | 72 | Citations (PDF) |
| 491 | Association of core promoter mutations with viral breakthrough in chronic hepatitis B patients on long‐term lamivudine therapy | 2.8 | 7 | Citations (PDF) |
| 492 | IDIOPATHIC BENIGN STRICTURES OF THE EXTRAHEPATIC BILE DUCT: RESULTS OF ENDOSCOPIC THERAPY | 3.5 | 1 | Citations (PDF) |
| 493 | Consensus on extra-hepatic portal vein obstruction | 4.2 | 220 | Citations (PDF) |
| 494 | Differentiating Acute Hepatitis B from the First Episode of Symptomatic Exacerbation of Chronic Hepatitis B | 2.2 | 49 | Citations (PDF) |
| 495 | Hepatic Venous Pressure Gradient in Cirrhosis: Role in Variceal Bleeding, Non-bleeding Complications and Outcome | 0.5 | 1 | Citations (PDF) |
| 496 | Endoscopic Management of Liver Abscesses and Cysts that Communicate with Intrahepatic Bile Ducts | 3.5 | 26 | Citations (PDF) |
| 497 | The hepatitis C virus NS5A protein and response to interferon α: mutational analyses in patients with chronic HCV genotype 3a infection from India | 3.0 | 8 | Citations (PDF) |
| 498 | Non-Cirrhotic Portal Fibrosis | 0.4 | 6 | Citations (PDF) |
| 499 | Endoscopic management of acute cholangitis in elderly patients | 4.7 | 45 | Citations (PDF) |
| 500 | Endoscopic Biliary Drainage by Nasobiliary Drain or by Stent Placement in Patients with Acute Cholangitis | 3.5 | 119 | Citations (PDF) |
| 501 | Higher Efficacy of Sequential Therapy with Interferon-alpha and Lamivudine Combination Compared to Lamivudine Monotherapy in HBeAg Positive Chronic Hepatitis B Patients | 0.4 | 48 | Citations (PDF) |
| 502 | Beneficial Effects of Tumor Necrosis Factor-alpha Inhibition by Pentoxifylline on Clinical, Biochemical, and Metabolic Parameters of Patients with Nonalcoholic Steatohepatitis | 0.4 | 177 | Citations (PDF) |
| 503 | Histological Spectrum of Chronic Hepatitis in Precore Mutants and Wild-Type Hepatitis B Virus Infection | 0.4 | 9 | Citations (PDF) |
| 504 | Bile duct obstruction due to portal biliopathy in extrahepatic portal hypertension: surgical management | 0.4 | 120 | Citations (PDF) |
| 505 | DIFFERENTIATING ACUTE VIRAL HEPATITIS B FROM FIRST EPISODE OF REACTIVATION OF CHRONIC HEPATITIS B | 0.4 | 1 | Citations (PDF) |
| 506 | Prevalence of autonomic dysfunction in cirrhotic and noncirrhotic portal hypertension | 0.4 | 46 | Citations (PDF) |
| 507 | Extrahepatic Portal Vein Obstruction | 3.4 | 184 | Citations (PDF) |
| 508 | Vertical transmission of hepatitis B virus despite maternal lamivudine therapy | 35.3 | 60 | Citations (PDF) |
| 509 | Baculovirus as Mammalian Cell Expression Vector for Gene Therapy: An Emerging Strategy | 10.5 | 84 | Citations (PDF) |
| 510 | Profile, spectrum and significance of HBV genotypes in chronic liver disease patients in the Indian subcontinent | 2.8 | 227 | Citations (PDF) |
| 511 | GASTRIC VARICES AND PORTAL HYPERTENSIVE GASTROPATHY | 3.6 | 38 | Citations (PDF) |
| 512 | Combination of norfloxacin and cisapride in prevention of SBP in high risk patients: A new approach | 1.0 | 1 | Citations (PDF) |
| 513 | Enhanced Immunogenicity of Recombinant Hepatitis B Vaccine in Exposed Family Contacts of Chronic Liver Disease Patients | 1.7 | 1 | Citations (PDF) |
| 514 | Profile of hepatocellular carcinoma in India: An insight into the possible etiologic associations | 2.8 | 64 | Citations (PDF) |
| 515 | Portal biliopathy | 2.8 | 151 | Citations (PDF) |
| 516 | Autoimmune hepatitis in the Indian subcontinent: 7 years experience | 2.8 | 39 | Citations (PDF) |
| 517 | Title is missing! | 1.9 | 5 | Citations (PDF) |
| 518 | Beneficial effects of lamivudine in hepatitis B virus-related decompensated cirrhosis | 2.9 | 135 | Citations (PDF) |
| 519 | Beneficial influence of an indigenous low-iron diet on serum indicators of iron status in patients with chronic liver disease | 2.7 | 6 | Citations (PDF) |
| 520 | Comparison of Endoscopic Ligation and Propranolol for the Primary Prevention of Variceal Bleeding | 25.5 | 305 | Citations (PDF) |
| 521 | Acute Pancreatitis Associated With Viral Hepatitis: A Report of Six Cases With Review of Literature | 0.4 | 76 | Citations (PDF) |
| 522 | Identification of a novel surface mutant of hepatitis B virus in a seronegative chronic liver disease patient | 2.6 | 15 | Citations (PDF) |
| 523 | Endoscopic ligation plus sclerotherapy: two plus two make only three! | 0.7 | 15 | Citations (PDF) |
| 524 | A CASE OF HEPATOCELLULAR CARCINOMA ASSOCIATED WITH TROUBLESOME HYPOGLYCEMIA: MANAGEMENT BY CYTOREDUCTION USING PERCUTANEOUS ETHANOL INJECTION | 0.4 | 18 | Citations (PDF) |
| 525 | Prevention of first variceal bleed: an appraisal of current therapies | 0.4 | 11 | Citations (PDF) |
| 526 | Long-term follow-up of gastric variceal sclerotherapy: an eleven-year experience | 0.7 | 192 | Citations (PDF) |
| 527 | A randomized controlled trial of endoscopie variceal band ligation for primary prophylaxis of variceal bleeding | 1.4 | 115 | Citations (PDF) |
| 528 | Choledocholithiasis associated with portal biliopathy in patients with extrahepatic portal vein obstruction: Management with endoscopic sphincterotomy | 0.7 | 47 | Citations (PDF) |
| 529 | Improved survival with percutaneous ethanol injection in patients with large hepatocellular carcinoma | 1.4 | 12 | Citations (PDF) |
| 530 | Management of gastric varices | 1.3 | 46 | Citations (PDF) |
| 531 | Caroli disease: Computed tomographic diagnosis | 0.8 | 10 | Citations (PDF) |
| 532 | Propranolol ameliorates the development of portal-systemic shunting in a chronic murine schistosomiasis model of portal hypertension. | 9.1 | 94 | Citations (PDF) |
| 533 | Splanchnic and systemic hemodynamics in mice using a radioactive microsphere technique | 3.5 | 27 | Citations (PDF) |
| 534 | Predictors of variceal bleeding: an analysis of clinical, endoscopic, and haemodynamic variables, with special reference to intravariceal pressure. | 14.8 | 38 | Citations (PDF) |
| 535 | Non-cirrhotic portal fibrosis. | 14.8 | 60 | Citations (PDF) |
| 536 | ENDOSCOPIC SCLEROTHERAPY FOR ESOPHAGO‐GASTRIC VARICES: A CRITICAL REAPPRAISAL | 0.5 | 8 | Citations (PDF) |
| 537 | Pattern of psychiatric morbidity and alcohol dependence in patients with alcoholic liver disease | 2.2 | 18 | Citations (PDF) |
| 538 | Pulmonary hemodynamic changes after intravariceal sclerotherapy with absolute alcohol | 0.7 | 18 | Citations (PDF) |
| 539 | Ulceration after Esophageal and Gastric Variceal Sclerotherapy - Influence of Sucralfate and Other Factors on Healing | 3.5 | 18 | Citations (PDF) |
| 540 | Young v adult cirrhotics: a prospective, comparative analysis of the clinical profile, natural course and survival. | 14.8 | 36 | Citations (PDF) |
| 541 | Intravariceal versus paravariceal sclerotherapy: a prospective, controlled, randomised trial. | 14.8 | 84 | Citations (PDF) |
| 542 | Measurement and correlation of wedged hepatic, intrahepatic, intrasplenic and intravariceal pressures in patients with cirrhosis of liver and non-cirrhotic portal fibrosis. | 14.8 | 86 | Citations (PDF) |
| 543 | Relative efficacy and safety of absolute alcohol and 50% alcohol as variceal sclerosants | 0.7 | 16 | Citations (PDF) |
| 544 | Significance of eosinophil and mast cell counts in rectal mucosa in ulcerative colitis | 2.2 | 71 | Citations (PDF) |
| 545 | Follow-up of Patients after Variceal Eradication | 4.9 | 82 | Citations (PDF) |
| 546 | Cholesterol and pigment gallstones in Northern India | 2.2 | 32 | Citations (PDF) |
| 547 | Oesophageal Ulceration after Sclerotherapy - A Complication or an Accompaniment? | 3.5 | 37 | Citations (PDF) |
| 548 | Comparison of the two time schedules for endoscopic sclerotherapy: a prospective randomised controlled study. | 14.8 | 72 | Citations (PDF) |
| 549 | Repeated Endoscopic Sclerotherapy for Active Variceal Bleeding | 4.9 | 29 | Citations (PDF) |
| 550 | Endoscopic sclerotherapy using absolute alcohol. | 14.8 | 40 | Citations (PDF) |
| 551 | Noradrenaline in Upper Gastrointestinal Haemorrhage | 0.4 | 1 | Citations (PDF) |
| 552 | Laparoscopy in carcinoma of the gallbladder | 0.7 | 10 | Citations (PDF) |
| 553 | Carcinoid tumour of ampulla of Vater associated with viscero-cutaneous neurofibromatosis | 1.9 | 17 | Citations (PDF) |
| 554 | Evaluation of the Point of Care Molecular Diagnostic Genedrive HCV ID Kit for the detection of HCV RNA in clinical samples | 2.0 | 7 | Citations (PDF) |
